Neuroimaging Changes in Menkes Disease, Part 1

R Manara1, L D'Agata2, M C Rocco3

  • 1From the Neuroradiology (R. Manara, M.C.R.), Sezione di Neuroscienze, Medicine and Surgery Department, University of Salerno, Salerno, Italy rmanara@unisa.it.

Insights

Menkes disease, a rare X-linked copper metabolism disorder, shows early vascular abnormalities and later myelination delays. Understanding these brain changes aids early diagnosis and treatment monitoring.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • Menkes disease is a rare, X-linked disorder affecting copper metabolism.
  • Neurologic involvement is early, severe, and progressive, but brain pathology is not fully understood.

Purpose of the Study:

  • To define the frequency, timing, imaging features, and evolution of intracranial vascular and white matter changes in Menkes disease.
  • To improve understanding of brain injury mechanisms and identify potential biomarkers.

Main Methods:

  • Retrospective and review Magnetic Resonance (MR) imaging study.
  • Analysis of intracranial vascular and white matter changes over disease progression.

Main Results:

  • Striking, poorly evolutive vascular abnormalities are present in early disease stages.
  • Myelination delay and focal white matter lesions become evident after initial months, some showing age-specific vulnerability.
  • Neurodegeneration in later stages may impede myelination.

Conclusions:

  • The evolution of neuroradiologic findings offers insights for early Menkes disease diagnosis.
  • MR imaging biomarkers may help assess new treatment efficacy.
  • This study enhances comprehension of brain injury mechanisms in Menkes disease.